TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
ARAY

Accuray Incorporated

Healthcare · Medical Devices

0.2151$ -3.5% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Cash Flow

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Cash Flow ARAY
Line item 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
-4.4% 8.4% -0.1% 4.5% -7.1% -0.4% 9.7% -0.6% 3.5% -2.7% 0.6% -1.7%
5.1% 4.6% 4.7% 2.4% 2.5% 2.0% 1.6% 1.3% 1.0% 1.3% 1.3% 2.0%
3.7% 3.2% 3.6% 3.0% 2.5% 2.1% 2.4% 2.5% 2.2% 2.1% 2.2% 1.6%
4.3% 4.0% 4.1% 4.3% 3.7% 3.4% 4.3% 3.7% 1.5% – – –
-5.8% 4.0% -3.3% 2.5% -11.2% -5.7% 2.0% -5.3% 1.0% -4.9% -4.0% 3.0%
2.8% 2.0% 1.4% 1.6% 1.0% 1.0% 0.6% 1.1% 2.8% 0.8% 1.9% 1.5%
1.0% 2.1% 4.6% 4.4% -1.0% -1.0% -0.6% -1.1% -2.8% -0.8% -1.9% -3.1%
0.0% 0.0% 0.0% 0.0% – 0.6% 0.8% 0.1% 0.0% – – –
-0.2% -0.7% -0.4% -0.1% 0.9% -0.1% -3.6% -0.1% 0.0% 0.0% – –
-0.5% -0.4% -14.8% -7.8% 5.9% 6.4% -4.4% -3.5% -0.9% -1.3% 1.6% 1.9%
1.6% -0.2% -14.2% -6.8% 6.8% 7.0% -7.3% -3.6% -0.5% -0.9% -0.9% 1.7%
-3.4% 10.1% -9.6% 2.0% -1.3% 5.7% 2.1% -6.5% 0.2% -4.7% -1.8% -3.3%
-7.2% 6.4% -1.5% 2.9% -8.1% -1.4% 9.1% -1.7% 0.6% -3.5% -1.2% -3.2%

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?